Media
Media
Our latest press releases
Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer
22/02/2024
Hansa Biopharma Year-end report January-December 2023
Regulatory press release
02/02/2024
Hansa Biopharma provides update on business and key financials ahead of the JP Morgan Healthcare Conference
Regulatory press release
06/01/2024
Imlifidase met primary endpoint in 16-HMedIdes-12 phase 2 trial in patients with AMR following kidney transplantation
Regulatory press release
14/12/2023
Media
News and insights
Neutralizing antibodies: Addressing barriers to gene therapy treatment
31/01/2024
At the intersection of patient-centered care and disruptive science
24/10/2023
Building a better knowledge of anti-GBM disease
10/05/2023
Acknowledging Disparities Between Sexes in Kidney Transplantation this World Kidney Day
09/03/2023